ARCHIVES

New Chemotherapy, Other Modality Progress Described

This article is from The Cancer Letter archive.

Vol. 05 No. 13 | March 30, 1979

Download PDF Visit The Full Archive

Related Articles

MSK Starts Ovarian Cancer Program

November 21, 1986

In Brief: Lichter, Bailes Lead ASCO; NCI Names Vande Woude Basic Sciences Director

May 22, 1998

ASCO Calls For New Clinical Study Section, Endorses NCAB Action In Senate Testimony

July 23, 1993

Also Von Eschenbach role in industry program raises new concerns of conflict of interest.

November 23, 2005

FDA News:: ODAC Commends Ciba For Design Of Trials Legal Issues:

January 10, 1997

DCPC Advisors Begin Process Of Setting Priorities For Research

June 21, 1991